methionine has been researched along with diphenyleneiodonium in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Angelini, GD; Jeremy, JY; Jones, RA; Koupparis, A; Persad, R; Shukla, N | 1 |
Feng, L; Han, C; Li, M; Liu, J; Mao, J; Pang, X; Wang, S; Wu, D; Zhang, X; Zhao, J | 1 |
Abbruzzese, JL; Bi, Y; Hu, L; Huang, H; Ji, J; Kim, E; Li, X; Li, Z; Liu, M; Lu, W; Luo, CK; Luo, Y; Ma, J; Wang, D; Wang, G; Yang, VW; Zhu, L | 1 |
3 other study(ies) available for methionine and diphenyleneiodonium
Article | Year |
---|---|
Penicillamine administration reverses the inhibitory effect of hyperhomocysteinaemia on endothelium-dependent relaxation and superoxide formation in the aorta of the rabbit.
Topics: Acetophenones; Acetylcholine; Administration, Oral; Animals; Aorta; Blotting, Western; Cyclic GMP; Dietary Supplements; Dose-Response Relationship, Drug; Endothelium, Vascular; Enzyme Inhibitors; Homocysteine; Hyperhomocysteinemia; In Vitro Techniques; Methionine; NADPH Oxidases; Nitric Oxide Donors; Nitroprusside; Onium Compounds; Penicillamine; Rabbits; Superoxides; Time Factors; Vasodilation; Vasodilator Agents | 2006 |
Homocysteine induces the expression of C-reactive protein via NMDAr-ROS-MAPK-NF-κB signal pathway in rat vascular smooth muscle cells.
Topics: Animals; Atherosclerosis; C-Reactive Protein; Cells, Cultured; Dizocilpine Maleate; Gene Expression Regulation; Homocysteine; Hyperhomocysteinemia; Interleukins; Male; MAP Kinase Signaling System; Methionine; Mitogen-Activated Protein Kinases; Myocytes, Smooth Muscle; NF-kappa B; Onium Compounds; Phosphorylation; Protein Kinase Inhibitors; Protein Processing, Post-Translational; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Receptors, N-Methyl-D-Aspartate; RNA, Messenger; Signal Transduction; Superoxides; Thenoyltrifluoroacetone | 2014 |
Selective killing of cancer cells harboring mutant RAS by concomitant inhibition of NADPH oxidase and glutathione biosynthesis.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Pancreatic Ductal; Cell Death; Colonic Neoplasms; Enzyme Inhibitors; Female; Genes, p53; Genes, ras; Glutamate-Cysteine Ligase; Glutathione; HCT116 Cells; Humans; Methionine; Mice, Nude; Mice, Transgenic; Mutation; NADPH Oxidases; Onium Compounds; Ovarian Neoplasms; Oxidative Stress; Pancreatic Neoplasms; Signal Transduction; Sulfoxides; Tumor Burden; Xenograft Model Antitumor Assays | 2021 |